Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Sight Sciences, Inc.SGHT · Entity 5537 | Director | July 19, 2021 | July 20, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Sight Sciences, Inc.
Report date July 19, 2021 · Filed July 20, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,162 |
Reported balance
After 2021-07-19 transaction · row 1
1 source rowRow 1 · 2021-07-19 · Conversion · Acquired 3,162 · Balance 3,162 F1: The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 2,355,062 |
Reported balance
After 2021-07-19 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2021-07-19 · Conversion · Acquired 2,225,752 · Balance 2,355,062 F1: The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. F2: These shares are held of record by Scientific Health Development II, Ltd. ("SHD II"). SHD Management, LLC is the manager of SHD II. The reporting person is the Chief Executive Officer of SHD Management, LLC and may be deemed to beneficially own the shares of common stock held by SHD II. |
| Series C Preferred StockSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-07-19 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-07-19 · Conversion · Disposed 1,581 · Balance 0 F1: The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. |
| Series A Redeemable Convertible Preferred StockSEC Table II · derivative / convertible security | IndirectSee footnote | 0 |
Reported balance
After 2021-07-19 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-07-19 · Conversion · Disposed 1,086,956 · Balance 0 F1: The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. F2: These shares are held of record by Scientific Health Development II, Ltd. ("SHD II"). SHD Management, LLC is the manager of SHD II. The reporting person is the Chief Executive Officer of SHD Management, LLC and may be deemed to beneficially own the shares of common stock held by SHD II. |
| Series B Redeemable Convertible Preferred StockSEC Table II · derivative / convertible security | IndirectSee footnote | 0 |
Reported balance
After 2021-07-19 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-07-19 · Conversion · Disposed 25,920 · Balance 0 F1: The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. F2: These shares are held of record by Scientific Health Development II, Ltd. ("SHD II"). SHD Management, LLC is the manager of SHD II. The reporting person is the Chief Executive Officer of SHD Management, LLC and may be deemed to beneficially own the shares of common stock held by SHD II. |
Filing footnotes · ownership attribution and instrument terms
F1: The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering.
F2: These shares are held of record by Scientific Health Development II, Ltd. ("SHD II"). SHD Management, LLC is the manager of SHD II. The reporting person is the Chief Executive Officer of SHD Management, LLC and may be deemed to beneficially own the shares of common stock held by SHD II.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 19, 2021 Filed Jul 20, 2021 00:17 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | ConversionSeries B Redeemable Convertible Preferred Stock · Derivative | 25,920 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-028880 · doc4.xml · derivative · entry 5 Offer Andrew · CIK 0001870371 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 51,840 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. F1 · price: The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. F1 · derivative.exercise_date: The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. F1 · derivative.expiration_date: The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. F2 · ownership.nature: These shares are held of record by Scientific Health Development II, Ltd. ("SHD II"). SHD Management, LLC is the manager of SHD II. The reporting person is the Chief Executive Officer of SHD Management, LLC and may be deemed to beneficially own the shares of common stock held by SHD II. Read SEC document |
| July 19, 2021 Filed Jul 20, 2021 00:17 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | ConversionSeries A Redeemable Convertible Preferred Stock · Derivative | 1,086,956 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-028880 · doc4.xml · derivative · entry 4 Offer Andrew · CIK 0001870371 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 2,173,912 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. F1 · price: The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. F1 · derivative.exercise_date: The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. F1 · derivative.expiration_date: The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. F2 · ownership.nature: These shares are held of record by Scientific Health Development II, Ltd. ("SHD II"). SHD Management, LLC is the manager of SHD II. The reporting person is the Chief Executive Officer of SHD Management, LLC and may be deemed to beneficially own the shares of common stock held by SHD II. Read SEC document |
| July 19, 2021 Filed Jul 20, 2021 00:17 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | ConversionSeries C Preferred Stock · Derivative | 1,581 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-028880 · doc4.xml · derivative · entry 3 Offer Andrew · CIK 0001870371 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,162 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. F1 · price: The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. F1 · derivative.exercise_date: The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. F1 · derivative.expiration_date: The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. Read SEC document |
| July 19, 2021 Filed Jul 20, 2021 00:17 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | ConversionCommon Stock | 2,225,752 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-028880 · doc4.xml · nonDerivative · entry 2 Offer Andrew · CIK 0001870371 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,355,062 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. F2 · ownership.nature: These shares are held of record by Scientific Health Development II, Ltd. ("SHD II"). SHD Management, LLC is the manager of SHD II. The reporting person is the Chief Executive Officer of SHD Management, LLC and may be deemed to beneficially own the shares of common stock held by SHD II. Read SEC document |
| July 19, 2021 Filed Jul 20, 2021 00:17 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | ConversionCommon Stock | 3,162 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-028880 · doc4.xml · nonDerivative · entry 1 Offer Andrew · CIK 0001870371 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,162 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.